VIOV:ARCA-Vanguard S&P Small-Cap 600 Value (USD)

ETF | Small Value | NYSE Arca

Last Closing

USD 88

Change

+2.41 (+2.82)%

Market Cap

USD 0.15B

Volume

0.05M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

The investment seeks to track the performance of a benchmark index that measures the investment return of small-capitalization value stocks in the United States. The fund employs an indexing investment approach designed to track the performance of the S&P SmallCap 600? Value Index, which represents the value companies, as determined by the index sponsor, of the S&P SmallCap 600 Index. The Advisor attempts to replicate the target index by investing all, or substantially all, of its assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index.

Inception Date: 07/09/2010

Primary Benchmark: S&P SmallCap 600 Value TR USD

Primary Index: S&P 500 TR USD

Gross Expense Ratio: 0.2%

Management Expense Ratio: 0.20 %

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Holdings

N/A

Symbol Company Name Allocation
TLSI TriSalus Life Sciences Inc. 0.71 %
Top Sectors

N/A

Top Regions

N/A

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-03-27 )

Largest Industry Peers for Small Value

Symbol Name Mer Price(Change) Market Cap
VBR Vanguard Small-Cap Value Index.. 0.07 %

N/A

USD 55.51B
IJS iShares S&P Small-Cap 600 Valu.. 0.25 %

N/A

USD 7.23B
SLYV SPDR® S&P 600 Small Cap Value.. 0.15 %

N/A

USD 4.00B
DES WisdomTree U.S. SmallCap Divid.. 0.38 %

N/A

USD 2.00B
RWJ Invesco S&P SmallCap 600 Reven.. 0.39 %

N/A

USD 1.55B
XSVM Invesco S&P SmallCap Value wit.. 0.39 %

N/A

USD 0.78B
XSLV Invesco S&P SmallCap Low Volat.. 0.25 %

N/A

USD 0.33B
RFV Invesco S&P MidCap 400® Pure .. 0.35 %

N/A

USD 0.30B
RZV Invesco S&P SmallCap 600® Pur.. 0.35 %

N/A

USD 0.22B
FDM First Trust Dow Jones Select M.. 0.60 %

N/A

USD 0.18B

ETFs Containing VIOV

N/A

Market Performance

  Market Performance vs. Industry/Classification (Small Value) Market Performance vs. Exchange (NYSE Arca)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -0.56% 27% F 29% F
Dividend Return 0.23% 18% F 11% F
Total Return -0.34% 9% A- 26% F
Trailing 12 Months  
Capital Gain 11.15% 27% F 55% F
Dividend Return 2.10% 64% D 30% F
Total Return 13.25% 36% F 51% F
Trailing 5 Years  
Capital Gain 38.13% 40% F 66% D+
Dividend Return 9.58% 80% B- 36% F
Total Return 47.71% 60% D- 64% D
Average Annual (5 Year Horizon)  
Capital Gain 9.91% 64% D 72% C
Dividend Return 11.50% 55% F 72% C
Total Return 1.59% 82% B 39% F
Risk Return Profile  
Volatility (Standard Deviation) 33.45% 64% D 33% F
Risk Adjusted Return 34.38% 45% F 60% D-
Market Capitalization 0.15B 55% F 59% D-

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.